Online citations, reference lists, and bibliographies.
← Back to Search

25% Albumin Infusion Maintains Antithrombin III (AT) Activity After AT AgentAdministration In Critically Ill Patients With Disseminated IntravascularCoagulation (DIC)

M. Aibiki, N. Fukuoka, B. Shiro, H. Matsumoto, M. Ohshita, Souichi Maekawam, Jun Takebe
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Objective: To report for the first time critically ill patients with disseminated intravascular coagulation (DIC) in whom the infusion of 25% albumin solution produces remarkable elevations in plasma antithrombin III (AT) activities after administration of AT agents. Design: A prospective observational study. Interventions: 1) Plasma AT activities were serially measured in DIC patients after AT administration, enable us to analyze their pharmacokinetics; 2) Comparisons of AT activities between two groups of receiving AT agent with or without the infusion of 25% albumin solution; 3) in vitro examinations were conducted to define whether albumin application itself would influence directly an AT measurement system using samples already determined the levels of AT activities. Methods and main results: Twenty consecutive critical patients with DIC were divided into two groups: groups receiving AT agents of 1500 units with (N=11) and without (N=9) the application of 25% albumin solutions. Patients treated with albumin solutions after AT agents showed remarkable elevations in AT peak and trough activities, whereas patients receiving the same dose of the AT agents without albumin co-administration did not maintain its trough activity. Pharmacokinetic analyses revealed that patients had shortened the distribution half-life time of AT, suggesting enhanced vascular permeability. The levels of AT activities in patients treated with both albumin and AT agents (N=11) were significantly higher than those without albumin administration (N=9, p=0.01). Furthermore, in vitro albumin applications to the AT measurement system did not effect on its values in the samples. Conclusion: This is the first report indicating that 25% albumin administration could elevate and sustain AT activities, even when a limited AT dose was administered to DIC patients with increased vascular permeability. This may be due to a certain binding effect of albumin, which needs to be defined in the future.
This paper references
Caring for the Critically Ill Patient
D. Angus (2007)
Serum albumin levels anticipate antithrombin III (AT) activities before and after AT agent in critical patients with disseminated intravascular coagulation
M Aibiki (2007)
10.1007/s001340051236
Antithrombin III in patients with severe sepsis: a pharmacokinetic study
W. Ilias (2000)
10.1007/s00134-003-1662-x
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
M. Levy (2003)
25% Albumin Infusion Maintains Antithrombin III (AT) Activity after AT Agent Administration in Critically Ill Patients with Disseminated Intravascular Coagulation (DIC)
10.1016/j.thromres.2008.07.006
Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis.
S. Gando (2009)
10.1056/NEJM199908193410807
Disseminated Intravascular Coagulation
M. Levi (1999)
Changes in post-administered Antithrombin III activity in congenital AT III deficiency patients
M Nakagawa (1985)
10.1016/J.JSS.2004.07.019
Albumin impacts the effects of tonicity on microvascular hydraulic permeability.
G. Victorino (2004)
167-172
GP Victorino (2014)
10.1074/jbc.274.41.29303
The Three Recombinant Domains of Human Serum Albumin
M. Dockal (1999)
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
B. L. Warren (2001)
10.1097/shk.0b013e31803422c4
DIFFERENCES IN ANTITHROMBIN III ACTIVITIES BY ADMINISTRATION METHOD IN CRITICAL PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION: A PHARMACOKINETIC STUDY
M. Aibiki (2007)
10.1097/01.shk.0000239762.90335.68
SERUM ALBUMIN LEVELS ANTICIPATE ANTITHROMBIN III ACTIVITIES BEFORE AND AFTER ANTITHROMBIN III AGENT IN CRITICAL PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
M. Aibiki (2007)
10.1159/000408471
Treatment of DIC with antithrombin III concentrates.
Y. Sakata (1983)
10.1055/S-2002-30200
Purity, activity, and virus safety of a pasteurized antithrombin concentrate.
A. Groener (2002)
10.1248/BPB1978.4.879
A pharmacokinetic analysis program (multi) for microcomputer.
K. Yamaoka (1981)
10.1097/01.CCM.0000050454.01978.3B
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
M. Levy (2003)
10.1001/JAMA.286.15.1869
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Brian Warren (2001)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar